News & Videos - English

Synchrony Makes a Big Splash in Connecticut Celebrating a Decade of Polar Plunges to Support Charity PR Newswire STAMFORD, Conn., March 7, 2025 STAMFORD, Conn. , March 7, 2025 /PRNewswire/ -- Synchrony (NYSE: SYF) employees, in a heartwarming display of courage and compassion, today braved icy waters at The Point at Norwalk Cove for the tenth consecutive celebration of their annual "Doubles Dive." The goal of the plunge is to raise vital funds for Connecticut -based nonprofit SeriousFun...

AUGA group, AB under restructuring (code126264360, registered office address Konstitucijos ave 21C, Vilnius, hereinafter - the Company) hereby provides additional information on the Extraordinary General Meeting of Shareholders to be held on 19 March 2025 (hereinafter - the Meeting). As announced on February 24, 2025, by the initiative of minority shareholders, the agenda of the meeting includes the revocation of the current Board and the election of a new one. The minority shareholders and...

Frontier Airlines Joins JFK Terminal 6 for Operations in 2026 PR Newswire NEW YORK, March 7, 2025 NEW YORK , March 7, 2025 /PRNewswire/ -- JFK Millennium Partners (JMP), the company selected by the Port Authority of New York & New Jersey to build and operate John F. Kennedy International Airport's new world-class Terminal 6 (T6), and ultra-low fare carrier Frontier Airlines, ( Nasdaq: ULCC ), today announced that Frontier has selected T6 for its future operations at JFK. Frontier joins Air...

QUBT Investors Have Opportunity to Lead Quantum Computing Inc. Securities Fraud Lawsuit with the Schall Law Firm PR Newswire LOS ANGELES, March 7, 2025 LOS ANGELES , March 7, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Quantum Computing Inc. ("Quantum Computing" or "the Company") (NASDAQ: QUBT ) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b -5 promulgated...

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. 07-March-2025 / 14:30 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming...

LEI: 213800NNT42FFIZB1T09 7 March 2025 FORESIGHT GROUP HOLDINGS LIMITED (the "Company") Notification of Transactions by Persons Discharging Managerial Responsibilities ("PDMRs") The Company was notified on 6 March 2025 that Geoffrey Gavey, Non-Executive Director and PDMR purchased ordinary shares of NIL par value each in the Company. Formal notification in respect of the PDMR is set out below. This announcement is made in accordance with Article 19 of the UK version of the EU Market Abuse...

MEXICO CITY, March 07, 2025 (GLOBE NEWSWIRE) -- Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE: VLRS and BMV: VOLAR) (“Volaris” or “the Company”), the ultra-low-cost carrier (ULCC) serving Mexico, the United States, Central and South America, reports its February 2025 preliminary traffic results. In February, Volaris’ ASM capacity increased by 3.4% year-over-year, while RPMs for the month grew by 2.5%. Mexican domestic RPMs increased 3.6%, while international RPMs...

Omaha, NE, March 07, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. (“FitLife,” or the “Company”) (Nasdaq: FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it plans to report its financial performance for the fourth quarter and full year of fiscal 2024 on Thursday, March 27, 2025. In addition, the Company announced that it will hold an investor conference call after market close on March 27, 2025 at 4:30 pm ET. Investors...

AS Inbank has proposed the following amendments to the Inbank Articles of Association for approval at the Annual General Meeting of Shareholders on 31 March 2025: 6.3 The Supervisory Board has a right, within 3 (three) years as of the entry into force of the version of the articles of association, to increase the share capital by monetary contributions by EUR 76,000, i.e. to increase the share capital to the amount of EUR 1,227,966.30. 7.9 The Bank may be represented in transactions and legal...

The Vanguard Group, Inc. (IRSH) Form 8.3 - The Vanguard Group, Inc.: Dalata Hotel Group plc 07-March-2025 / 14:29 GMT/BST Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Full name of discloser The Vanguard Group, Inc. Owner or controller of interests and short positions disclosed, if different from...

Miami International Holdings Announces Launch of Hourly Bitcoin Range Binary Options on MIAXdx PR Newswire MIAMI and PRINCETON, N.J., March 7, 2025 MIAMI and PRINCETON, N.J. , March 7, 2025 /PRNewswire/ -- Miami International Holdings, Inc. (MIH), a technology-driven leader in building and operating regulated financial markets across multiple asset classes, today announced the launch of Bitcoin Range Binary (BTCRB) Options on its MIAX Derivatives Exchange (MIAXdx™). BTCRB Options are...

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc 07-March-2025 / 14:28 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle...

LONDON and PHILADELPHIA, March 07, 2025 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT), a life sciences company developing next generation peptide drug conjugates (PDC) targeting powerful anti-tumor payloads directly to the tumor, is pleased to announce that the lead program of the Company, AVA6000, the first clinical stage asset which is a pre|CISION ® -enabled form of doxorubicin, has completed the Phase 1a dose escalation with encouraging PFS data in patients with salivary gland...

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc 07-March-2025 / 14:28 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or...

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Assura plc 07-March-2025 / 14:27 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is...

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Aviva plc 07-March-2025 / 14:26 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is...

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Dowlais Group plc 07-March-2025 / 14:25 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle...

SAN DIEGO, March 07, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced that Capricor management will participate in one-on-one investor meetings and provide a corporate update at Leerink’s Global Healthcare Conference 2025, taking place March 10-12, 2025 in Miami, Florida. Leerink’s Global Healthcare Conference 2025 Presentation Date:...

NTLA Investors Have Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm PR Newswire LOS ANGELES, March 7, 2025 LOS ANGELES , March 7, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Intellia Therapeutics, Inc. ("Intellia" or "the Company") (NASDAQ: NTLA ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b -5 promulgated...

ATKR Investors Have Opportunity to Lead Atkore Inc. Securities Fraud Lawsuit with the Schall Law Firm PR Newswire LOS ANGELES, March 7, 2025 LOS ANGELES , March 7, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Atkore Inc. ("Atkore" or "the Company") (NYSE: ATKR ) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b -5 promulgated thereunder by the U.S. Securities and...